ASSESSMENT TRIAL OF THE EFFECT OF SYL1001 DRUG IN PATIENTS WITH OCULAR PAIN

PILOT TRIAL FOR ASSESSMENT TOLERABILITY AND EFFECT OF SYL1001 IN PATIENS WITH OCULAR PAIN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-001177-93-ES

Enrollment

Registered

2012-07-19

Start date

2012-10-18

Completion date

Unknown

Last updated

2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PATIENTS WITH DIAGNOSIS OF OCULAR PAIN MILD TO MODERATE AND DRY EYE MILD TO MODERATE

Interventions

Product Name: SYL1001 Product Code: SYL1001 Pharmaceutical Form: Eye drops, solution INN or Proposed INN: SYL1001 Current Sponsor code: SYL1001 Concentration unit: mg milligram(s) Concentration type:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Main Objective: ANALGESIC EFFECT AND TOLERABILITY OF SYL1001 IN PATIENTS WITH DRY EYE AND OCULAR PAIN;Secondary Objective: Ocular tolerability SAE assessment Analytical parameters;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Secondary

Measure	Time frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Countries

Spain

Contacts

Public ContactVerónica Ruz

Sylentis

vruz@sylentis.com918063188

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026